Skip to nav Skip to content


December 12, 2018


IDSA Survey: Impacts of Diagnostics Payment Cuts on Near Patient Testing

Outpatient clinical laboratory tests will receive the second of three expected 10 percent reimbursement cuts on Jan. 1, 2019. These rates do not reflect market-based payments as intended by Congress under the Protecting Access to Medicare Act (PAMA).

IDSA, COLA (the leading laboratory accreditation program for CLIA certified clinical laboratories), and other organizations remain concerned that the myriad issues with PAMA implementation have led to inappropriate new reimbursement rates for many tests. The group is working to advocate for a reimbursement system that promotes innovative diagnostics and improves patient access to care, and we need your help to provide on-the-ground perspectives about the importance of near patient testing in the diagnosis and treatment of infectious diseases.

Please complete and share the brief survey here on the impacts of declining reimbursement on laboratory operations and patient care. Email questions or additional comments to Thank you helping to protecting patient access to diagnostic testing.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.